ARX788 in HER2-positive Metastatic Breast Cancer Patients Who Were Previously Treated With T-DXd
Clinical trial NCT06578286 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06578286
- Sponsor
- Fudan University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-30
- Primary completion
- 2026-09-30
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.